Design, synthesis and computational study of new benzofuran hybrids as dual PI3K/VEGFR2 inhibitors targeting cancer.
Autor: | El-Khouly OA; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, P.O. Box 35516, Mansoura, Egypt.; Faculty of Pharmacy, New Mansoura University, P.O. Box 35712, New Mansoura, Egypt., Henen MA; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, P.O. Box 35516, Mansoura, Egypt.; Department of Biochemistry and Molecular Genetics, University of Colorado, Denver, USA., El-Sayed MA; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, P.O. Box 35516, Mansoura, Egypt.; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University, P.O. Box 34518, New Damietta, Egypt., El-Messery SM; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, P.O. Box 35516, Mansoura, Egypt. habib2001@mans.edu.eg.; Faculty of Pharmacy, New Mansoura University, P.O. Box 35712, New Mansoura, Egypt. habib2001@mans.edu.eg. |
---|---|
Jazyk: | angličtina |
Zdroj: | Scientific reports [Sci Rep] 2022 Oct 12; Vol. 12 (1), pp. 17104. Date of Electronic Publication: 2022 Oct 12. |
DOI: | 10.1038/s41598-022-21277-2 |
Abstrakt: | Design and synthesis of a new series of benzofuran derivatives has been performed. 1 H-NMR, 13 C-NMR, elemental analysis, and IR were used to confirm the structures of the produced compounds. Hepatocellular carcinoma (HePG2), mammary gland breast cancer (MCF-7), epithelioid carcinoma cervical cancer (Hela), and human prostate cancer are used to test anticancer activity (PC3). In compared to DOX (4.17-8.87 µM), Compound 8 demonstrated the highest activity against HePG and PC3 cell lines, with an IC (© 2022. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |